Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc. (TMO)
Compare

TMO Balance Sheet

Assets, liabilities, and equity analysis

TMO Quarterly Balance Sheet (USD)

Quarterly ReportTTM
03/28/2026
12/31/2025
09/27/2025
06/28/2025
03/29/2025
12/31/2024
09/28/2024
06/29/2024
Total Current Assets
22.316B22.316B28.707B22.295B24.584B23.378B22.137B23.783B25.476B
3.254B3.254B9.857B1.982B4.579B4.134B4.019B4.645B7.084B
Short-Term Investments
2.000M2.000M253.000M1.564B1.814B1.813B1.561B2.000B1.750B
Cash & Short-Term Investments
3.256B3.256B10.110B3.546B6.393B5.947B5.580B6.645B8.834B
9.204B9.204B10.566B8.911B10.035B9.821B9.626B9.796B9.430B
5.496B5.496B5.425B5.745B5.559B5.224B4.978B5.430B5.198B
Total Assets
113.281B113.281B110.343B103.020B101.230B99.041B97.321B100.364B98.496B
10.658B10.658B12.012B10.177B9.635B9.331B10.795B9.412B9.282B
55.187B55.187B49.362B49.287B47.249B46.493B45.853B46.726B43.843B
Intangible Assets
19.146B19.146B15.838B16.242B15.148B15.323B15.533B16.262B15.519B
Long-Term Investments
0.000.00541.000M435.000M198.000M374.000M560.000M106.000M492.000M
Total Current Liabilities
14.621B14.621B15.189B14.888B12.718B13.174B13.332B14.601B14.772B
3.344B3.344B3.622B2.980B2.980B3.049B3.079B2.606B2.547B
3.090B3.090B3.808B3.823B2.214B2.819B2.475B4.116B5.121B
Total Liabilities
61.341B61.341B56.807B51.996B50.628B49.555B47.650B51.265B50.963B
40.071B40.071B35.852B31.857B33.015B31.370B29.061B31.197B30.284B
43.161B43.161B40.855B35.680B35.229B34.189B32.775B35.313B35.405B
Net Debt (Cash)
39.907B39.907B30.998B33.698B30.650B30.055B28.766B30.668B28.321B
Total Shareholders' Equity
51.940B51.940B53.407B51.024B50.511B49.390B49.584B48.992B47.432B
Common Stock
445.000M445.000M445.000M444.000M444.000M444.000M444.000M444.000M443.000M
60.632B60.632B59.156B55.901B55.901B54.447B53.102B51.421B49.940B
1.531.531.891.501.931.771.661.631.72
0.830.830.760.700.700.690.660.720.75

TMO Annual Balance Sheet (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Current Assets
28.707B22.137B24.589B25.229B20.113B21.957B11.893B10.625B
9.857B4.019B8.083B8.524B4.477B10.325B2.399B2.103B
Short-Term Investments
253.000M1.561B0.000.000.000.000.000.00
Cash & Short-Term Investments
10.110B5.580B8.083B8.524B4.477B10.325B2.399B2.103B
10.566B9.626B9.664B9.427B8.945B6.472B4.952B4.595B
5.425B4.978B5.088B5.634B5.051B4.029B3.370B3.005B
Total Assets
110.343B97.321B98.726B97.154B95.123B69.052B58.381B56.232B
12.012B10.795B11.004B10.873B9.864B6.687B5.448B4.165B
49.362B45.853B44.020B41.196B41.924B26.041B25.714B25.347B
Intangible Assets
15.838B15.533B16.670B17.478B20.146B12.685B14.014B14.978B
Long-Term Investments
541.000M560.000M59.000M155.000M73.000M65.000M35.000M53.000M
Total Current Liabilities
15.189B13.332B14.012B17.010B13.436B10.304B6.197B6.147B
3.622B3.079B2.872B3.381B2.867B2.175B1.920B1.615B
3.808B2.475B3.872B5.851B2.803B2.812B843.000M1.271B
Total Liabilities
56.807B47.650B51.884B53.006B54.146B34.535B28.706B28.646B
35.852B29.061B31.308B28.909B32.148B19.107B17.076B17.719B
40.855B32.775B36.424B36.073B36.339B22.545B18.490B18.990B
Net Debt (Cash)
30.998B28.766B28.341B27.549B31.862B12.220B16.070B16.875B
Total Shareholders' Equity
53.407B49.584B46.735B43.978B40.793B34.507B29.675B27.586B
Common Stock
445.000M444.000M442.000M441.000M439.000M437.000M434.000M432.000M
59.156B53.102B47.364B41.910B35.431B28.116B22.092B18.696B
1.891.661.751.481.502.131.921.73
0.760.660.780.820.890.650.620.69

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Waltham, MA
125,000 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Marc N. Casper